It operates in the world of money and finance. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
The stock trades 28% below its peak. The market has trimmed its expectations for the company.
The company sells $2.6B a year; the problem isn’t sales — it’s costs running above that number.
A loss of $95.7M against $2.6B in annual sales.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
Over the last 12 months, executives reported 10 sells against just 2 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, THCPW sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: THCPW has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.